Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Synergy CHC Corp. (SNYR : NSDQ)
 
 • Company Description   
Synergy CHC Corp. is a provider of consumer health care, beauty and lifestyle products. The company's current brand portfolio consists of marquee brands, FOCUSfactor, a clinically-tested brain health supplement and Flat Tummy, a lifestyle and wellness brand which provides a suite of nutritional products to help women achieve their weight management goals. Synergy CHC Corp. is based in Westbrook, Maine.

Number of Employees: 21

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.19 Daily Weekly Monthly
20 Day Moving Average: 84,235 shares
Shares Outstanding: 9.44 (millions)
Market Capitalization: $20.73 (millions)
Beta:
52 Week High: $7.65
52 Week Low: $1.30
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.79% -5.59%
12 Week -38.17% -40.49%
Year To Date -50.11% -56.34%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
865 SPRING STREET
-
WESTBROOK,ME 04092
USA
ph: 207-321-2350
fax: -
snyr@gateway-grp.com http://www.synergychc.com
 
 • General Corporate Information   
Officers
Jack Ross - Chief Executive Officer and Chairman
Jaime Fickett - Chief Financial Officer
Alfred Baumeler - Director
J. Paul SoRelle - Director
Nitin Kaushal - Director

Peer Information
Synergy CHC Corp. (CHCR)
Synergy CHC Corp. (ESRX)
Synergy CHC Corp. (MYDP)
Synergy CHC Corp. (COR)
Synergy CHC Corp. (GBCS)
Synergy CHC Corp. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 87165D208
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/13/25
Share - Related Items
Shares Outstanding: 9.44
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $20.73 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.13 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.41 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 5.35
Trailing 12 Months: 5.78
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 8.25
Price / Sales: 0.64
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 70.00%
Sales Growth
vs. Year Ago Period: -16.07%
vs. Previous Quarter: -17.57%
ROE
09/30/25 - -
06/30/25 - -18.56
03/31/25 - -11.62
ROA
09/30/25 - -
06/30/25 - 20.28
03/31/25 - 17.48
Current Ratio
09/30/25 - -
06/30/25 - 2.74
03/31/25 - 1.91
Quick Ratio
09/30/25 - -
06/30/25 - 2.41
03/31/25 - 1.62
Operating Margin
09/30/25 - -
06/30/25 - 10.02
03/31/25 - 7.20
Net Margin
09/30/25 - -
06/30/25 - 10.02
03/31/25 - 7.20
Pre-Tax Margin
09/30/25 - -
06/30/25 - 9.93
03/31/25 - 7.09
Book Value
09/30/25 - -
06/30/25 - -1.35
03/31/25 - -1.79
Inventory Turnover
09/30/25 - -
06/30/25 - 4.80
03/31/25 - 5.35
Debt-to-Equity
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Capital
09/30/25 - -
06/30/25 - -
03/31/25 - -
 

Powered by Zacks Investment Research ©